Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.

× No keyword cloud information.

28 in total

1. Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors.

Authors: S K Sankhla; J S Nadkarni; S N Bhagwati
Journal: J Neurooncol Date: 1996-02 Impact factor: 4.130

2. IL-2 induces the release of secondary cytokines which stimulate the cytotoxic activity of either NK or CD8(+) lymphocytes.

Authors: U Testa; D Bulgarini; E Montesoro; E Tritarelli; G Boccoli; A Camagna; F Calabresi; C Peschle
Journal: Cytotechnology Date: 1991-02 Impact factor: 2.058

Review 3. Endogenous substances as drugs. Issues related to the application of cytokines in cancer therapy.

Authors: D R Parkinson
Journal: Drug Saf Date: 1990 Impact factor: 5.606

4. In vivo biology of recombinant interleukin-2 infusion in sheep: cardiopulmonary manifestations of an intravascular immune-inflammatory response.

Authors: G J Jesmok; R A Gunther
Journal: Inflammation Date: 1989-06 Impact factor: 4.092

5. Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.

Authors: S D Voss; J A Hank; C A Nobis; P Fisch; J A Sosman; P M Sondel
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

6. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Authors: S A Rosenberg; M T Lotze; J C Yang; P M Aebersold; W M Linehan; C A Seipp; D E White
Journal: Ann Surg Date: 1989-10 Impact factor: 12.969

7. Kupffer cells and pit cells are not effective in the defense against experimentally induced colon carcinoma metastasis in rat liver.

Authors: P Griffini; S M Smorenburg; I M Vogels; W Tigchelaar; C J Van Noorden
Journal: Clin Exp Metastasis Date: 1996-09 Impact factor: 5.150

8. A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice.

Authors: B J Drucker; F M Marincola; D Y Siao; T A Donlon; C D Bangs; W D Holder
Journal: In Vitro Cell Dev Biol Date: 1988-12

9. Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.

Authors: P M Anderson; F H Bach; A C Ochoa
Journal: Cancer Immunol Immunother Date: 1988 Impact factor: 6.968

10. Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer.

Authors: M Scudeletti; G Filaci; M A Imro; G Motta; M Di Gaetano; I Pierri; S Tongiani; F Indiveri; F Puppo
Journal: Cancer Immunol Immunother Date: 1993-07 Impact factor: 6.968